awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36237990-596601EB-FEA0-4F45-A5FC-3DDDABE8EC38
Q36237990-596601EB-FEA0-4F45-A5FC-3DDDABE8EC38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36237990-596601EB-FEA0-4F45-A5FC-3DDDABE8EC38
Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.
P2860
Q36237990-596601EB-FEA0-4F45-A5FC-3DDDABE8EC38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36237990-596601EB-FEA0-4F45-A5FC-3DDDABE8EC38
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b9e66f0bf46430609249f68073aaa00365e22c7f
P2860
Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity